SPC358
Satralísúmab
Status:
VeittApplication date:
10.11.2021Application published:
15.12.2021Grant published:
15.7.2023
Max expiry date:
24.9.2034Medicine name:
EnspryngMedicine for children:
No
Timeline
Today
10.11.2021Application
15.12.2021Publication
15.7.2023Registration
24.9.2034Expires
Marketing license
IS authorization number:
EU/1/21/1559/001Date:
15.7.2021
Foreign authorization number:
EU/1/21/1559Date:
24.6.2021
Owner
Name:
Chugai Saiyaku Kabushiki KaishaAddress:
5-1, Ukima 5-chome, Kita-ku, Tokyo JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2330193